Research, science & health

William Richardson, Pr. at the University College of London (UCL), was at the Institut du Cerveau - ICM on June the 13st 2016. He talks about the important role of oligodendrocytes for learning in adult brain.

Teams from the Assistance Publique-Hôpitaux de Paris, the Pierre and Marie Curie University, the Inserm and the CarThera company, hosted at the Brain and Spine Institute (Institut du Cerveau - ICM), coordinated by professor Alexandre Carpentier...

In our representation of the world, how do we link an electron and the moon ? Through analogical reasoning ! Both gravitate around a nucleus or around earth. Analogical reasoning is a thinking process enabling us to notice a similarity between two...

Basic research in the field of nutrition has enabled to develop, in animals, a system regulating the expression of a gene through a specific diet leading to original therapeutic applications. Developed by a team from the Human Nutrition Unit (Inra...

Trisomy 21 is the first genetic cause of intellectual disabilities, and currently cognitive rehabilitation is the only therapeutic approach offered to patients. A phase II clinical trial conducted by an international team involving researchers from...

Professor Adrian Isaacs, neuroscientist at the London University College (UCL), was the Institut du Cerveau - ICM's guest on April 18, 2016. On this occasion, he discusses his research on C9orf72 gene, which unusual mutation is at the origin of two...

A specialist in genetics of epilepsy, Stephanie Baulac, co-responsible of the team "genetics and physiopathology of family epilepsies" at the Institut du Cerveau - ICM, is the winner of an ERC Consolidator Grant.

A major international conceptual diagnostic criteria and conceptual breakthrough program has been successfully launched and published, led by the UPMC and Institut du Cerveau - ICM researchers Professor Bruno Dubois and Professor Harald Hampel (AXA –...

A team coordinated by professor Emmanuel Flamand-Roze of the Pitié-Salpêtrière hospital, AP-HP, and researcher at the Brain and Spine Institute, has tested at the Institut du Cerveau - ICM Clinical Investigation Center, the efficiency of zonisamide...

In the context of World Parkinson's disease day on April 11th, the Institut du Cerveau - ICM focuses on the latest discoveries.

Hereditary spastic paraplegias are a heterogeneous group of pathologies and share clinical similarities with other neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS).

In a rare and early form of Alzheimer's disease, Institut du Cerveau - ICM researchers have shown that, surprisingly, connectivity between neurons increases during the initial phase of the disease. This transitional increase would correspond to a...